Welcome to our dedicated page for Revitalist Lifes news (Ticker: RVLWF), a resource for investors and traders seeking the latest updates and insights on Revitalist Lifes stock.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF, FSE: 4DO) generates news that reflects its role in the ketamine and psychedelic wellness segment of mental health care. Company announcements highlight its focus on comprehensive care in the ketamine wellness space, combining clinic operations, telemedicine, partnerships, and advocacy initiatives.
News coverage for Revitalist includes updates on its mental health and wellness services, such as expansions of physical clinic locations and virtual offices across the United States, and joint-venture agreements that broaden access to ketamine therapies and related services. Releases have described brick-and-mortar services in multiple U.S. cities, virtual telemedicine offerings across numerous states, and managed service agreements with other health and wellness facilities.
Investors and observers can also find news on Revitalist’s product collaborations and supplement initiatives. For example, the company has announced the Lion's Brain supplement line, a cobranded joint-venture with Wake Network that combines Revitalist’s proprietary formula with medicinal mushrooms and other ingredients aimed at supporting mental clarity and wellbeing. Additional news items describe evidence-based clinical retreats and neurologically focused supplements developed with partners.
Capital markets and regulatory developments are another key theme in Revitalist’s news flow. The company has issued releases about non-brokered private placements, unit offerings with share purchase warrants, and the use of proceeds for operations and financial reporting. It has also reported on a cease trade order issued by the British Columbia Securities Commission related to delayed financial filings, subsequent filing of audited financial statements, and steps toward addressing regulatory requirements.
Revitalist’s news feed further covers community and professional engagement, including sponsorship of The American Legion’s national convention to support veteran mental health, and speaking engagements on psychedelics in anesthesia at professional congresses. Readers following RVLWF news can track how the company communicates its role in the evolving field of ketamine and psychedelic wellness, its partnerships, financing activities, and regulatory updates over time.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF) has partnered with M-Lend Financial to offer patient financing up to $100,000 for treatments, including ketamine and psychedelic medicine. Clients can finance treatments with monthly payments starting at $42 for a ketamine series. Revitalist aims to increase client appointments to 900 per month, potentially boosting revenues significantly from an initial treatment cost of $3,300.
Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) continues to enhance its financial standing and operational strategies. The company has extinguished contracts with High Standard Capital and Tannoy Digital Inc., canceling 424,000 shares and issuing 1,282,051 shares at $0.078 each. Additionally, debts totaling $300,000 CAD were settled with Natasha Collins and Larry Heinzlmeir, involving interest and warrants. This strategic maneuvering aims to strengthen the company's outlook as it operates nine clinics across six U.S. states, focusing on psychedelic medicine.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF) has partnered with Wake Network to offer ketamine infusions and psilocybin retreats, focusing on veterans' mental health needs. They are establishing an international center to provide ethical access to psychedelic treatments. The first retreat occurs from October 10-17 at the Veteran’s Healing Farm in North Carolina, followed by a psilocybin retreat in Jamaica. Revitalist aims to expand services while ensuring timely care and quality education for veterans.
Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) is expanding its mental health services for Veterans through funding from the Veterans Health Administration (VHA). The company reports a remarkable 300% month-over-month growth in Veterans seeking care. With plans to establish over 100 new locations nationwide, Revitalist aims to address the mental health needs of the estimated 13.5 million Veterans who are not currently utilizing their benefits. The VHA budget exceeds $80 billion, presenting a significant market opportunity for the company.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF) announces strategic growth opportunities in the psychedelic wellness sector. CEO Kathryn Walker highlights the company’s expansion following board member resignations, including Patrick Gray and Aaron Bowden, effective August 18, 2022. New board members Corby Marshall and Kevin Murray bring extensive experience in leadership and finance, respectively. This restructuring aims to enhance Revitalist's mission, particularly in veteran wellness and diversified revenue generation.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF) has entered into a licensing partnership with Awakn Life Sciences Corp. (NEO: AWKN, OTCQB: AWKNF) to implement the KARE® protocol for treating Alcohol Use Disorder. Awakn's ketamine-assisted therapy demonstrates significant improvements over current treatment standards, achieving an 86% abstinence rate in post-treatment trials. Revitalist will incur an annual licensing fee and share revenue from services. The U.S. alcohol treatment industry, worth over $30B, faces high relapse rates, which this partnership aims to address.
Revitalist Lifestyle and Wellness Ltd. has successfully closed the second tranche of its private placement offering, raising a total of $3,944,000. This brings the total funds raised since inception to over $15.2 million, enabling the company to enhance operations and improve mental health services nationwide. Each of the 3,944 convertible note units issued includes $1,000 in principal amount and 3,500 detachable common share purchase warrants. The net proceeds will be allocated for working capital purposes.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF) reported a remarkable 626% year-over-year revenue growth for Q1 2022, totaling
Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) reported a spectacular revenue growth of 319% year-over-year for April 2022, reaching approximately $480,000 CAD. Additionally, the company announced partnerships with over 80 medical providers, facilitating in-network insurance coverage with major plans, enhancing consumer financial security. Revitalist is set to present research findings on ketamine treatment at the American Psychiatric Nursing Association’s National Conference. CEO Kathryn Walker emphasized strong company performance amid market challenges and the successful closure of a $3,869,000 financing tranche.
Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) reported significant growth for the year ended December 31, 2021. The company raised over $11 million and increased patient visits by 128%, totaling over 5,000 visits. Sales surged 110% to $2,067,456. Revitalist expanded operations by opening 9 clinics and launching new service lines, including Mental Health Coaching. With cash reserves of $3.9 million, the company plans further expansion and development in the psychedelic wellness sector. CEO Kathryn Walker highlights the firm's growth as a foundation for future initiatives.
FAQ
What is the current stock price of Revitalist Lifes (RVLWF)?
What is the market cap of Revitalist Lifes (RVLWF)?
